Invacare Corporation
IVC · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.04 | 0.22 | -0.27 |
| FCF Yield | -384.88% | -33.36% | -0.13% | -2.68% |
| EV / EBITDA | -5.38 | 159.45 | 20.88 | 225.43 |
| Quality | ||||
| ROIC | -12.85% | -2.59% | 1.79% | -1.96% |
| Gross Margin | 23.65% | 27.41% | 28.83% | 28.24% |
| Cash Conversion Ratio | 0.55 | 0.31 | -0.78 | -0.05 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.47% | -2.03% | -4.36% | -1.35% |
| Free Cash Flow Growth | -84.43% | -8,170.54% | 95.24% | 85.54% |
| Safety | ||||
| Net Debt / EBITDA | -5.19 | 111.69 | 8.74 | 74.16 |
| Interest Coverage | -2.44 | -0.61 | 0.40 | -0.36 |
| Efficiency | ||||
| Inventory Turnover | 5.03 | 4.39 | 5.24 | 5.53 |
| Cash Conversion Cycle | 48.42 | 57.20 | 64.71 | 63.70 |